Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.72 |
| ▸ | HRH1 | P35367 | 1/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetylcarnitine SCHEMBL10904306 | 0.88 | MEN1 (0.87) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Acetylcarnitine SCHEMBL10904308 | 0.88 | MEN1 (0.87) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Phytic Acid SCHEMBL1360053 | 0.86 | MEN1 (0.52) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Phytic Acid SCHEMBL1358555 | 0.86 | MEN1 (0.74) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Acetylcarnitine SCHEMBL69781 | 0.85 | MEN1 (1.00) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Acetylcarnitine SCHEMBL677128 | 0.85 | MEN1 (1.00) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Acetylcarnitine SCHEMBL118455 | 0.85 | MEN1 (1.00) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Acetylcarnitine SCHEMBL28017793 | 0.85 | MEN1 (1.00) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL1359383 | 0.84 | MEN1 (0.49) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Phytic Acid SCHEMBL1358559 | 0.84 | MEN1 (0.61) | MEN1KMT2ACYP1A2HRH1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101903020-B | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | SCIAN LAB LLC | 2013-04-10 | — | — | CN | claimed |
| US-8067468-B2 | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | SCIAN LABORATORIES, LLC | 2011-11-29 | — | — | US | claimed |
| JP-2011524415-A | — | — | 2011-09-01 | — | — | JP | claimed |
| EP-2299994-A1 | L-CARNITINE AND ALKANOYL L-CARNITINE PHYTATES AND PROCESS FOR PREPARING THE SAME | Scian Laboratories, Llc (US) | 2011-03-30 | — | — | EP | claimed |
| US-20100317890-A1 | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | SCIAN LABORATORIES, LLC (US) | 2010-12-16 | — | — | US | claimed |
| CN-101903020-A | L-carnitine phytate and alkanoyl L-carnitine phytate and preparation thereof | SCIAN LAB LLC | 2010-12-01 | — | — | CN | claimed |
| WO-2010005465-A1 | L-CARNITINE AND ALKANOYL L-CARNITINE PHYTATES AND PROCESS FOR PREPARING THE SAME | SCIAN LABORATORIES, LLC (US) | 2010-01-14 | — | — | WO | claimed |
| CN-101903020-B | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | SCIAN LAB LLC | 2013-04-10 | — | — | CN | disclosed |
| US-8067468-B2 | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | SCIAN LABORATORIES, LLC | 2011-11-29 | — | — | US | disclosed |
| EP-2299994-A1 | L-CARNITINE AND ALKANOYL L-CARNITINE PHYTATES AND PROCESS FOR PREPARING THE SAME | Scian Laboratories, Llc (US) | 2011-03-30 | — | — | EP | disclosed |
| US-20100317890-A1 | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | SCIAN LABORATORIES, LLC (US) | 2010-12-16 | — | — | US | disclosed |
| CN-101903020-A | L-carnitine phytate and alkanoyl L-carnitine phytate and preparation thereof | SCIAN LAB LLC | 2010-12-01 | — | — | CN | disclosed |
| WO-2010005465-A1 | L-CARNITINE AND ALKANOYL L-CARNITINE PHYTATES AND PROCESS FOR PREPARING THE SAME | SCIAN LABORATORIES, LLC (US) | 2010-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317890-A1 | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | CPT1A, CPT1B, SLC25A20 | MEN1 330/4885KMT2A 1438/4885CYP1A2 2417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.